Skip to main navigation
Skip to search
Skip to main content
Experts@Minnesota Home
Home
Profiles
Research units
University Assets
Projects and Grants
Research output
Press/Media
Datasets
Activities
Fellowships, Honors, and Prizes
Search by expertise, name or affiliation
Metabolism of Antiepileptic Medication: Newborn to Elderly
Ilo E. Leppik
Experimental and Clinical Pharmacology
Research output
:
Contribution to journal
›
Article
›
peer-review
40
Scopus citations
Overview
Fingerprint
Fingerprint
Dive into the research topics of 'Metabolism of Antiepileptic Medication: Newborn to Elderly'. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Keyphrases
Metabolism
100%
Antiepileptic Drugs
100%
Carbamazepine
28%
Valproate
28%
Epilepsy
14%
High Dose
14%
Ataxia
14%
Infant Patients
14%
Neurologic Deficit
14%
Adverse Effects
14%
All Ages
14%
Drug Concentration
14%
Age-specific
14%
Relative Amount
14%
Serum Albumin Concentration
14%
Hepatotoxicity
14%
Therapeutic Levels
14%
Metabolic Rate
14%
Drug Metabolism
14%
Low Serum Albumin
14%
Neurotoxic Effects
14%
Hyponatremia
14%
Children's Needs
14%
Gingival Hyperplasia
14%
Drug Elimination
14%
Cognitive Disturbances
14%
Neonatal Infants
14%
Epileptologists
14%
Nursing and Health Professions
Anticonvulsive Agent
100%
Drug Therapy
100%
Valproic Acid
33%
Carbamazepine
33%
Neonates
16%
Drug Concentration
16%
Epileptologist
16%
Adverse Event
16%
Metabolic Rate
16%
Liver Toxicity
16%
Gingiva Hyperplasia
16%
Hyponatremia
16%
Serum Albumin
16%
Drug Metabolism
16%
Ataxia
16%
Pharmacology, Toxicology and Pharmaceutical Science
Anticonvulsive Agent
100%
Sodium Valproate
33%
Carbamazepine
33%
Elimination
16%
Drug Concentration
16%
Hepatotoxicity
16%
Adverse Event
16%
Gingiva Hyperplasia
16%
Serum Albumin
16%
Drug Metabolism
16%
Ataxia
16%
Hyponatremia
16%